Comparison of Effect on Quality of Recovery Outcome Between Systemic

See also
Status	Clinical Trial	Phase
Completed	`NCT02185586` - A Prospective Randomized Controlled Trial of Lower Abdominal Three-port Laparoscopic Cholecystectomy	N/A
Recruiting	`NCT06278090` - Impact of Ursodeoxycholic Acid Treatment on the Gallbladder Polyp Evolution
Withdrawn	`NCT02492685` - Quantificational Enhancement Pattern Analysis Using a Novel Software "Vuebox" of Contrast-enhanced Harmonic Endoscopic Ultrasonography for Differential Diagnosis Between Adenomas and Cholesterol Polyps	N/A

See also

Status

Clinical Trial

Phase

Completed

NCT02185586 - A Prospective Randomized Controlled Trial of Lower Abdominal Three-port Laparoscopic Cholecystectomy

N/A

Recruiting

NCT06278090 - Impact of Ursodeoxycholic Acid Treatment on the Gallbladder Polyp Evolution

Withdrawn

NCT02492685 - Quantificational Enhancement Pattern Analysis Using a Novel Software "Vuebox" of Contrast-enhanced Harmonic Endoscopic Ultrasonography for Differential Diagnosis Between Adenomas and Cholesterol Polyps

N/A

Interventional studies are often prospective and are specifically tailored to evaluate direct impacts of treatment or preventive measures on disease.

Observational studies are often retrospective and are used to assess potential causation in exposure-outcome relationships and therefore influence preventive methods.

Expanded access is a means by which manufacturers make investigational new drugs available, under certain circumstances, to treat a patient(s) with a serious disease or condition who cannot participate in a controlled clinical trial.

Clinical trials are conducted in a series of steps, called phases - each phase is designed to answer a separate research question.

Phase 1: Researchers test a new drug or treatment in a small group of people for the first time to evaluate its safety, determine a safe dosage range, and identify side effects.
Phase 2: The drug or treatment is given to a larger group of people to see if it is effective and to further evaluate its safety.
Phase 3: The drug or treatment is given to large groups of people to confirm its effectiveness, monitor side effects, compare it to commonly used treatments, and collect information that will allow the drug or treatment to be used safely.
Phase 4: Studies are done after the drug or treatment has been marketed to gather information on the drug's effect in various populations and any side effects associated with long-term use.

NCT number	NCT02224170
Study type	Interventional
Source	Yonsei University
Contact
Status	Terminated
Phase	N/A
Start date	November 2014
Completion date	March 2015

Comparison of Effect on Quality of Recovery Outcome Between Systemic Lidocaine and Dexamethasone in Patients Undergoing Laparoscopic Cholecystectomy

Clinical Trial Summary

Clinical Trial Description

Study Design

Related Conditions & MeSH terms